This article is more than 5 years old. Information may no longer be current.

Myeloproliferative Neoplasms and Myelodysplastic Syndrome Drugs in the Pipeline

Issue: March 25, 2016

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

HemOnc Today presents this guide to drugs in phase 2 or phase 3 development for myeloproliferative neoplasms and myelodysplastic syndrome. Clinicians can use this chart as a quick reference to learn about the status of those drugs that may be clinically significant to their practice.